Navigate the rapidly evolving treatment landscape for hypertrophic cardiomyopathy with Dr Anjali Tiku Owens, a renowned expert in inherited cardiovascular diseases and advanced heart failure.

This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, explores both established and emerging therapeutic approaches for obstructive and non-obstructive HCM, providing clinicians with essential insights into contemporary patient management.

Dr Tiku Owens addresses the complete spectrum of HCM management, from sudden cardiac death prevention and heart failure progression to the critical importance of anticoagulation in HCM patients with atrial fibrillation - noting that standard risk scoring doesn't apply in this high-risk population. She focuses extensively on symptomatic left ventricular outflow tract obstruction, reviewing established therapies including beta-blockers and disopyramide alongside septal reduction procedures.

The presentation concludes with exciting future developments, including ongoing trials of gene replacement therapy and novel sarcomere modulators, representing the next frontier in precision HCM treatment.

Stay tuned for more expert content from the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program.

About Women As One

Women As One is a global organization dedicated to empowering women in cardiology. They offer a variety of resources and programs, including the CLIMB Skills Training Program and the Women As One Talent Directory, a global community of women in cardiology.

Join the Women As One Community
Women physicians who are not yet part of the Women As One community can register for free here.